Dalia El-Gamal

14PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer.

|Jan 16, 2026
Molecular Profiling and Real-world Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer.

Martina Chirra, Andrew Elliott, Hira Shaikh

|Nov 05, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.

Sunandini Sharma, Roshia Ali, Alyssa Bouska

|Jul 31, 2025
Gut Microbiome Profiling in Eμ-TCL1 Mice Reveals Intestinal Changes and a Dysbiotic Signature Specific to Chronic Lymphocytic Leukemia.

Sydney A Skupa, Kathryn M Cooper, Audrey L Smith

|Jul 25, 2025
BET Protein Inhibition Relieves MDSC-Mediated Immune Suppression in Chronic Lymphocytic Leukemia.

Erin M Drengler, Audrey L Smith, Sydney A Skupa

|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Olga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz

Pageof 3

Frequent Collaborators

7 joint publications

Audrey L Smith

7 joint publications

Sydney A Skupa

5 joint publications

Alexandria P Eiken

4 joint publications

Erin M Drengler